12.45

0.48% 0.06

Core Laboratories Inc (CLB)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Core Laboratories Inc stock is traded at $12.45, with a volume of 474.99K. It is up +0.48% in the last 24 hours and up +7.79% over the past month. Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

Previous Close:

$12.39

Open:

$12.4

24h Volume:

474.99K

Relative Volume:

0.58

Market Cap:

$571.26M

Revenue:

$524.73M

Net Income/Loss:

$31.70M

P/E Ratio:

18.82

EPS:

0.6617

Net Cash Flow:

$22.47M

1W Performance:

+9.69%

1M Performance:

+7.79%

6M Performance:

-32.92%

1Y Performance:

+17.45%

1-Day Range:

$12.29

$12.85

1-Week Range:

$11.37

$12.85

52-Week Range:

$9.79

$20.36

Core Laboratories Inc Stock (CLB) Company Profile

Name

Core Laboratories Inc

Sector

Energy (257)

Industry

Oil & Gas Equipment & Services (52)

Phone

713-328-2673

Address

6316 WINDFERN ROAD, HOUSTON

Employee

3,300

Twitter

@corelabcompany

Next Earnings Date

2026-07-29

Latest SEC Filings

CLB's Discussions on Twitter

Compare CLB vs SLB, BKR, FTI, HAL, TS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLB Core Laboratories Inc	12.45	571.26M	524.73M	31.70M	22.47M	0.6617
SLB Slb Ltd	53.77	78.07B	35.91B	3.38B	4.41B	2.2806
BKR Baker Hughes Company	64.82	63.81B	27.89B	3.15B	2.29B	3.1363
FTI Technipfmc Plc	78.61	29.52B	10.17B	1.08B	1.34B	2.6138
HAL Halliburton Co	34.42	27.73B	22.37B	1.61B	1.73B	1.9091
TS Tenaris Sa Adr	53.58	26.83B	12.19B	2.03B	1.87B	3.8072

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-25	Upgrade	Citigroup	Sell → Neutral
Jun-30-23	Downgrade	Citigroup	Neutral → Sell
Apr-18-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-09-23	Upgrade	BofA Securities	Underperform → Neutral
Oct-07-22	Upgrade	Citigroup	Sell → Neutral
Sep-26-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Apr-18-22	Downgrade	Piper Sandler	Neutral → Underweight
Oct-18-21	Downgrade	BofA Securities	Neutral → Underperform
Jul-09-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-14-21	Downgrade	Citigroup	Neutral → Sell
Dec-18-20	Downgrade	JP Morgan	Neutral → Underweight
Nov-11-20	Reiterated	Cowen	Market Perform
Oct-13-20	Upgrade	BofA Securities	Underperform → Neutral
Sep-29-20	Upgrade	ABN Amro	Sell → Hold
Jul-16-20	Downgrade	Scotiabank	Sector Outperform → Sector Perform
Apr-13-20	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Mar-09-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-09-20	Downgrade	Evercore ISI	Outperform → In-line
Jan-31-20	Reiterated	Cowen	Market Perform
Jan-30-20	Resumed	Johnson Rice	Buy
Jan-14-20	Initiated	Bernstein	Mkt Perform
Jan-02-20	Downgrade	Stifel	Buy → Hold
Dec-31-19	Reiterated	Cowen	Market Perform
Jul-10-19	Upgrade	BofA/Merrill	Neutral → Buy
Feb-25-19	Upgrade	Tudor Pickering	Hold → Buy
Dec-19-18	Downgrade	Credit Suisse	Outperform → Neutral
Dec-11-18	Downgrade	JP Morgan	Overweight → Neutral
Nov-16-18	Upgrade	Guggenheim	Neutral → Buy
Nov-01-18	Upgrade	ABN Amro	Sell → Buy
Oct-29-18	Reiterated	Cowen	Market Perform

View All

Core Laboratories Inc Stock (CLB) Latest News

Aug 14, 2026

Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan

Aug 14, 2026

Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan

Aug 14, 2026

Aug 13, 2026

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - MarketBeat

Aug 13, 2026